GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Zim Laboratories Ltd

Zim Laboratories Board Meeting to Approve Audited Financial Results on May 19, 2026

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 12 May 2026, 05:06 PM IST  ·  BSE ID: 35eeecde-9d75-4a73-b0fb-8e093d017ed9
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on May 19, 2026, to approve its full-year financial results.
🤖 AI Summary
  • Zim Laboratories Board meeting scheduled for Tuesday, May 19, 2026.
  • Purpose is to consider and approve audited Standalone and Consolidated Financial Results.
  • Results pertain to the quarter and year ended March 31, 2026.
  • Trading window for insiders closed from April 01, 2026, to May 21, 2026 (inclusive).
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this intimation.
👤
Who Is Affected
All shareholders are affected as the company will disclose its financial performance for the full year. Insiders are restricted from trading company securities during the closed window.
🔍
Management Signal
The management is adhering to regulatory requirements by intimating the Board meeting and insider trading window closure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board Meeting Outcome on May 19, 2026 — details of approved financial results
Audited Financial Results — review Standalone and Consolidated performance for FY26
Any further corporate announcements post-Board meeting
LOW RISK The filing is a routine procedural intimation of a Board meeting.
💡 Investor Takeaway
Zim Laboratories Ltd has scheduled a Board of Directors meeting on May 19, 2026, to approve its audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The trading window for insiders remains closed from April 01, 2026, to May 21, 2026.
📅 Company Track Record
Zim Laboratories recently completed an investment of Rs. 89,45,100 in ZIMTAS Pty Ltd, securing a 99.96% stake, as disclosed on April 9, 2026, following earlier intimations from 2024.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.